ResearcherTsinghua UniversityActive in the last 2 years

Ziwei Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2357-259X; OpenAlex author ID A5101554490. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 2 papers

Papers 2

Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival. Co-author DOI 10.1158/0008-5472.can-24-2563 ↗
Targeting plasticity in the pyrimidine synthesis pathway potentiates macrophage-mediated phagocytosis in pancreatic cancer models. Co-author DOI 10.1172/jci193370 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mo Chen · 2 shared papers, 2025 · strength 0.53
- Paper Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival. DOI 10.1158/0008-5472.can-24-2563 ↗
- Paper Targeting plasticity in the pyrimidine synthesis pathway potentiates macrophage-mediated phagocytosis in pancreatic can… DOI 10.1172/jci193370 ↗
Charles J. David · 1 shared paper, 2025 · strength 0.30
- Paper Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival. DOI 10.1158/0008-5472.can-24-2563 ↗
Deng Pan · 1 shared paper, 2025 · strength 0.22
- Paper Targeting plasticity in the pyrimidine synthesis pathway potentiates macrophage-mediated phagocytosis in pancreatic can… DOI 10.1172/jci193370 ↗
Jie Zhao · 1 shared paper, 2025 · strength 0.22
- Paper Targeting plasticity in the pyrimidine synthesis pathway potentiates macrophage-mediated phagocytosis in pancreatic can… DOI 10.1172/jci193370 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.